Skip to main content

Modulation of NK activity by thymic hormones:in vitro effects of thymostimulin

Medical Oncology and Tumor Pharmacotherapy volume 6, pages 45–52 (1989)Cite this article

Abstract

Plastic-adherent depleted or not depleted peripheral mononuclear blood cells (PMBC) from healthy donors showed enhanced lytic activity against51Cr-labelled K562 target cells when exposed to thymostimulin (TS), 1 μg ml-1, for 3 h, washed and incubated in TS-free medium before testing for natural killer (NK) cytotoxicity. No modification of NK cell activity was seen when effector cells were treated with placebo (splenic extract). The NK boosting activity of TS was lost when effector cells were treated for 3 h immediately before the performance of the cytotoxic test or when this thymic extract was added directly to the mixture of effector and target cells during the lytic phase of51Cr release assay.

This is a preview of subscription content, access via your institution.

Access options

Buy single article

Instant access to the full article PDF.

43,34 €

Price includes VAT (Finland)
Tax calculation will be finalised during checkout.

References

  1. Schulof R S: Thymic peptide hormones: basic properties and clinical applications in cancer.CRC Crit Rev Oncol Hemat 3, 309 (1985).

    Article  CAS  Google Scholar 

  2. Lau C Y, Wang E Y, Goldstein G: Studies of thymopoietin pentapeptides (TP5) on experimental tumors. TP5 relieves immunosuppression in tumorbearing mice.Cell Immun 66, 217 (1982).

    Article  CAS  Google Scholar 

  3. Takeichi N, Koga Y, Fujii T, Kobayashi H: Restoration of T-cell function and induction of antitumor immune response in T-cell-depressed spontaneously hypertensive rats by treatment with thymosin fraction 5.Cancer Res 45, 487 (1985).

    PubMed  CAS  Google Scholar 

  4. Zatz M M, Glaser M, Seals C M, Goldstein A L: Effects of combined cyclophosphamide and thymosin treatment on tumor growth and host survival in mice bearing a syngeneic tumor, in Goldstein A L, Chirigos M A (eds):Cancer Therapeutics, p. 249. New York, Raven Press (1981).

    Google Scholar 

  5. Tovo P A, Bernengo M G, Cordero di Montezemolo L, Del Piano A, Saitta M, Nicola P: Thymus extract therapy in immunodepressed patients with malignancies and herpes virus infections.Thymus 2, 41 (1980).

    Google Scholar 

  6. Haneke E, Bolla K, Degreef H, Djawari D, Demaubeuge J, Molin L, Panconesi E, Schöpf E, Stengel R, Stingl G, Wolff K, Wüthrich B: The effect of thymopentin treatment on the relapse rate in frequently relapsing herpes simplex virus infections.Int J clin pharm Res 4, 439 (1984).

    CAS  Google Scholar 

  7. Martelli M F, Velardi A, Rambotti P, Cernetti C, Bertotto A, Spinozzi F, Bracaglia A M, Falini B, Davis S: Thein vivo effect of a thymic factor (thymostimulin) on immunologic parameters of patients with untreated Hodgkin’s disease.Cancer 50, 490 (1982).

    PubMed  Article  CAS  Google Scholar 

  8. Thurman G B, Seals C, Low T L K, Goldstein A L: Restorative effects of thymosin polypeptides on purified protein derivative dependent migration inhibition factor production by the peripheral blood lymphocytes of adult thymectomized guinea pigs.J biol Resp Mod 3, 160 (1984).

    CAS  Google Scholar 

  9. Neta R, Salvin S B: Resistance and susceptibility to infection in inbred murine strains. II. Variations in the effect of treatment with thymosin fraction 5 on the release of lymphokinesin vivo.Cell Immun 75, 173 (1983).

    Article  CAS  Google Scholar 

  10. Ohta Y, Tamura S, Nihira S, Tezuka E, Imai S, Yagi Y: Thymosin α1 enhances haemopoietic colony formation by stimulating the production of interleukin 3 innu/nu mice.Int J Immunopharmac 8, 773 (1986).

    Article  CAS  Google Scholar 

  11. Ohta Y, Tezuka E, Tamura S, Sugawara M, Nihira S, Imai S, Yagi Y: Thymosin-α increases the capability to produce interleukin-3 but not interleukin-2 innu/ nu mice.J biol Resp Mod 6, 181 (1987).

    CAS  Google Scholar 

  12. Zatz M M, Oliver J, Samuels C, Skotnicki A B, Sztein M B, Goldstein A L: Thymosin increases production of T-cell growth factor by normal human peripheral blood lymphocytes.Proc natn Acad Sci USA 81, 2882 (1984).

    Article  CAS  Google Scholar 

  13. Zatz M M, Oliver J, Sztein M B, Skotnicki A B, Goldstein A L: Comparison of the effects of thymosin and other thymic factors on modulation of interleukin-2 production.J biol Resp Mod 4, 365 (1985).

    CAS  Google Scholar 

  14. Liberati A M, Ballatori E, Fizzotti M, Schippa M, Cini L, Cinieri S, Proietti M G, Di Marzio R, Senatore M, Grignani F: A randomized trial to evaluate the immunorestorative properties of thymostimulin in patients with Hodgkin’s disease in complete remission.Cancer Immun Immunother 26, 87 (1988).

    CAS  Google Scholar 

  15. Palacios R: Role of serum thymic factor (FTS) in the development of interleukin-2 producer lymphocytes.Clin Immun Allergy 3, 83 (1983).

    CAS  Google Scholar 

  16. Grinblat J, Schauenstein K, Saltz E, Trainin N, Globerson A: Regulatory effects of thymus humoral factor on T cell growth factor in aging mice.Mech Ageing Devel 22, 209 (1983).

    Article  CAS  Google Scholar 

  17. Katorza E, Pecht M, Apte R N, Benharroch D, Burstein Y, Trainin N, Rager-Zisman B: Restoration of immunological responses by THF, a thymic hormone, in mice infected with murine cytomegalovirus (MCMV).Clin exp Immun 70, 268 (1987).

    PubMed  CAS  Google Scholar 

  18. Zatz M M, Goldstein A L: Mechanism of action of thymosin. I. Thymosin fraction 5 increases lymphokine production by mature murine T cells responcling in a mixed lymphocyte reaction.J Immun 134, 1032 (1985).

    PubMed  CAS  Google Scholar 

  19. Shoham J, Eshel I, Aboud M, Salzberg S: Thymic hormonal activity on human peripheral blood lymphocytesin vitro — II. Enhancement of the production of immune interferon by activated cells.J Immun 125, 54 (1980).

    PubMed  CAS  Google Scholar 

  20. Svedersky L P, Hui A, May L, McKay P, Stebbing N: Induction and augmentation of mitogen-induced immune interferon production in human peripheral blood lymphocytes by Nα-desacetylthymosin α1 Eur J Immun 12, 244 (1982).

    Article  CAS  Google Scholar 

  21. Huang K Y, Kind P D, Jagoda E J, Goldstein A L: Thymosin treatment modulates production of interferon.J Interfer Res 1, 411 (1981).

    CAS  Google Scholar 

  22. Henney C S, Kuribayashi K, Kern D E, Gillis S: Interleukin-2 augments natural killer cell activity.Nature 291, 335 (1981).

    PubMed  Article  CAS  Google Scholar 

  23. Kuribayashi K, Gillis S, Kern D E, Henney C: Murine NK cell cultures: effects of interleukin-2 and interferon on cell growth and cytotoxic reactivity.J Immun 126, 2321 (1981).

    PubMed  CAS  Google Scholar 

  24. Umeda Y, Sakamoto A, Nakamura J, Ishitsuka H, Yagi Y: Thymosin α1 restores NK cell activity and prevents tumor progression in mice immunosuppressed by cytostatics or X-rays.Cancer Immun Immunother 15, 78 (1983).

    CAS  Google Scholar 

  25. Favalli C, Jezzi T, Mastino A, Rinaldi-Garaci C, Riccardi C, Garaci E: Modulation of natural killer activity by thymosin alpha 1 and interferon.Cancer Immun Immunother 20, 189 (1985).

    CAS  Google Scholar 

  26. Bistoni F, Baccarini M, Pucetti P, Marconi P, Garaci E: Enhancement of natural killer cell activity in mice by treatment with a thymic factor.Cancer Immun Immunother 17, 51 (1984).

    CAS  Google Scholar 

  27. Serrate S, Schulof R S, Leondaridis L, Goldstein A L, Sztein M B: Modulation of human natural killer cell cytotoxic activity, lymphokine production, and interleukin 2 receptor expression by thymic hormones.J Immun 139, 2338 (1987).

    PubMed  CAS  Google Scholar 

  28. Liberati A M, Brugia M, Edwards B S, Bertoni P, Ballatori E, Puxeddu A, Grignani F: Immunorestorative properties of thymostimulin (TS) in patients with Hodgkin’s disease in clinical remission.Cancer Immun Immunother 19, 136 (1985).

    CAS  Google Scholar 

  29. Fiorilli M, Sirianni M C, Pandolfi F, Quinti I, Tosti U, Aiuti F, Goldstein G: Improvement of natural killer activity and of T cells after thymopoietin pentapeptide therapy in a patient with severe combined immunodeficiency.Clin exp Immun 45, 344 (1981).

    PubMed  CAS  Google Scholar 

  30. Bordigoni P, Bienie M C, Faure G, Donner M, Janot C, Dardenne M, Duheille J, Oliver D: Allogeneic bone marrow transplantation in man:in vitro activity of FTS-Zn on T-cell markers and functions.Br J Haemal 58, 661 (1984).

    Article  CAS  Google Scholar 

  31. Dokhelar M C, Tursz T, Dardenne M, Bach J F: Effect of synthetic thymic factor (facteur thymique serique) on natural killer cell activity in humans.Int J Immunopharmac 5, 277 (1983).

    Article  CAS  Google Scholar 

  32. Bardos P, Bach J F: Modulation of mouse natural killer cell activity by the serum thymic factor.Scand J Immun 15, 321 (1982).

    Article  Google Scholar 

  33. Kaiserlian D, Savino W, Dardenne M: Studies of the thymus in mice bearing the Lewis lung carcinoma — II. Modulation of thymic natural killer activity by thymulin (FTS-Zn) and the antimetastatic effect of zinc.Clin Immun Immunopath 28, 192 (1983).

    PubMed  Article  CAS  Google Scholar 

  34. Kaiserlian D, Bardos P, Bach J F:In vitro modulation of mouse natural killer (NK) cell activity by the serum thymic factor (FTS).Cell Immun 76, 232 (1983).

    Article  CAS  Google Scholar 

  35. Falchetti R, Bergesi G, Eshkol A, Cafiero C, Adorini L, Caprino L: Pharmacological and biological properties of a calf thymus extract (TP-1).Drugs exp clin Res 3, 39 (1977).

    Google Scholar 

  36. Bergesi G, Falchetti R: Caratterizzazione chimica ed attività biologica di un nuovo estratto timico.Fol Allerg Immun Clin 24, 204 (1977).

    Google Scholar 

  37. Liberati M, Borden E C, McBain J A, Raubertas R: Effects of levamisole on human natural killer and killer cell activity and production of interferons.Immunopharmacology 5, 11 (1982).

    PubMed  Article  CAS  Google Scholar 

  38. Hanna M:In vivo activities of NK cells against primary and metastatic tumors in experimental animals, in Lotzova E, Herberman R B (eds):Immunobiology of Natural Killer Cells, pp. 1–10. Boca Raton, FL, CRC Press (1986).

    Google Scholar 

Download references

Author information

Affiliations

  1. Clinica Medica I, University of Perugia, Italy

    Anna Marina Liberati, Saverio Cinieri, Marco Fizzotti, Monica Schippa, Stefano Ascani, Verena De Angelis & Maria Senatore

  2. Istituto Farmacologico “C. Serono”, Rome, Italy

    Lucia Palmisano

Authors
  1. Anna Marina Liberati
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Saverio Cinieri
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Marco Fizzotti
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Monica Schippa
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Stefano Ascani
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Verena De Angelis
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Maria Senatore
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Lucia Palmisano
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and Permissions

About this article

Cite this article

Liberati, A.M., Cinieri, S., Fizzotti, M. et al. Modulation of NK activity by thymic hormones:in vitro effects of thymostimulin. Med. Oncol. & Tumor Pharmacother. 6, 45–52 (1989). https://doi.org/10.1007/BF02985222

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF02985222

Key words

  • Thymostimulin
  • Natural killer
  • Thymic hormones